Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales

1,249.63 million and THB 729.06 million respectively. This equals to a sharp decline of 41.66% year on year. Domestic sales revenue dropped 43.82% from the same period of the previous year due to an

recorded total sales revenue of THB 733.57 million and THB 384.43 million respectively. This equals to a sharp decline of 47.59% year on year. Domestic sales revenue dropped 46.25% from the same period of

, the Company recorded total sales revenue of THB 983.36 million and THB 557.33 million respectively. This equals to a sharp decline of 4 3.32% year on year. Domestic sales revenue dropped 43.28% from the

quarter with net losses due to lockdown and the disruption of activities that occurred. Sales have not yet been able to adjust back to normal due to the novel coronavirus (COVID-19) outbreak, despite the

in world oil prices, resulting in a sharp drop in commodity prices this causes a lot of price competition. Yours Sincerely, Ms. Piyanan Suwannaphasri Assistant Managing Director Authorized to sign

fallen by THB 34.73 million, which has led 2nd quarter company’s net profit to fall to THB 0.69 million, a decrease of THB 16.05 million (96.2%). The main factors causing a sharp fall in underwriting

while expenses had grown, as a result; a huge drop in 6 months period by 137%. Profit (Loss) before tax: A sharp drop of 174% in 2Q19 comparing to 2Q18, while 6 months recorded a 91% less than the same

subsidiaries decreased because the Social Security Office have reduced the payment of medical expenses of high-cost deseases from 12,800.- to 10,200.-Baht,so the company has to adjust the revenue that was

months recorded a sharp increase by 573% from the same period of last year which was directly affected by a decrease in shares of loss and a lower of total expenses. Net Profit (Loss): EASON reported a net